---
id: derived-002-projection-2026-04-21T20:00
type: derived
subtype: memory_projection
subject: patient_002
encounter_id: enc-002-001
projection_at: "2026-04-21T20:00:00-05:00"
recorded_at: "2026-04-21T20:00:00-05:00"
window:
  start: "2026-04-19T04:10:00-05:00"
  end: "2026-04-21T20:00:00-05:00"
author:
  id: agent
  role: derived
source:
  kind: derived_from_events
  ref: timeline/2026-04-19/events.ndjson + timeline/2026-04-20/events.ndjson + timeline/2026-04-21/events.ndjson
status: snapshot
---

# Memory projection — patient_002 — 2026-04-21 20:00 (post-extubation, pre-transfer)

This is a derived synthesis composed at the end of hospital day 3,
reflecting the full ICU course up to the planned step-down transfer in
the morning. Every claim is anchored to the event(s) that support it.

## One-line summary
68F completing hospital day 3 of severe CAP with septic shock; extubated
this morning, off pressors >24h, antibiotics narrowed, AKI resolved —
ready for step-down transfer in the morning.

## What changed in the last 24 hours
- **Extubated** at 08:30 after passing SAT (RASS 0, follows commands)
  [evt-002-0116] and SBT (PS 5/PEEP 5/FiO2 0.30 for 30 min, RSBI 38, no
  distress) [evt-002-0117]; transitioned to HFNC 30L 35%, then weaned to
  20L 30% [evt-002-0124, evt-002-0135].
- **Sedation discontinued** with extubation; both propofol and fentanyl
  infusions stopped [evt-002-0126, evt-002-0127]. Patient now alert,
  oriented x 3, conversational, CAM-ICU negative [evt-002-0128].
- **Antibiotics narrowed.** Blood cultures speciated to coag-neg staph
  in a single bottle, confirmed contaminant [evt-002-0129]. Vancomycin
  and cefepime stopped; ceftriaxone 1 g IV q24h started, planned
  through 2026-04-24 [evt-002-0131, evt-002-0134].
- **AKI fully resolved.** Cr 1.4 = baseline [evt-002-0121]. WBC 11.2,
  back in normal range [evt-002-0121].
- **Home antihypertensive resumed.** Amlodipine 5 mg PO restarted at
  15:00 [evt-002-0140]; losartan to resume tomorrow if BP stable.
- **Lines de-escalated.** Left radial arterial line discontinued at 14:00
  [evt-002-0137]; OG tube removed at 16:30 [evt-002-0142]; central line
  remains for ceftriaxone overnight, planned removal in AM.
- **Diet resumed.** Tube feeds discontinued at 16:00 [evt-002-0141];
  patient tolerating soft diet without difficulty.

## Course summary (3 days)
| Day | Trajectory milestones |
|-----|----------------------|
| Day 1 (04-19) | ED arrival in septic shock → 30 mL/kg fluids → vanc + cefepime within 45 min → ICU transfer at 06:45 → CVC, art line, Foley, norepi → HFNC failure → intubation at 09:30 → stabilized on AC/VC FiO2 0.5 |
| Day 2 (04-20) | Lactate normalized, WBC trending down, CXR improving, AKI improving; norepi weaned to off at 16:00; sedation lightened RASS −1; tube feeds started; ID consulted; cultures preliminary as likely contaminant |
| Day 3 (04-21) | SAT/SBT passed, extubated 08:30; cultures finalized as contaminant; abx narrowed to ceftriaxone; AKI resolved; advancing diet; planning floor transfer |

## Evidence anchors (key)
- Septic shock from CAP: lactate 3.8 [evt-002-0025], procalcitonin 4.2
  [evt-002-0026], CXR consolidation [evt-002-0021], persistent MAP <65
  despite fluids [evt-002-0038].
- Hypoxemic respiratory failure: ABG sequence pH 7.31 → 7.26 → 7.32 →
  7.40 [evt-002-0030, evt-002-0057, evt-002-0067, evt-002-0120].
- AKI on CKD: Cr 2.1 → 2.0 → 1.7 → 1.5 → 1.4 [evt-002-0024, evt-002-0086,
  evt-002-0093, evt-002-0113, evt-002-0121].
- Cultures: single-bottle GPC at 30 h [evt-002-0103] → coag-neg staph
  contaminant [evt-002-0129].
- Extubation: passed SAT [evt-002-0116] and SBT [evt-002-0117]; ABG 7.40
  on PS5/PEEP5/FiO2 0.30 [evt-002-0120].

## Uncertainty
- **No pathogen identified for the pneumonia.** Sputum culture not
  obtained pre-antibiotic (intubation occurred without bronchoscopy).
  Treating empirically; ceftriaxone is appropriate for typical CAP.
- **Voice hoarseness** post-extubation noted [evt-002-0128]; expected
  post-intubation phenomenon but warrants monitoring for stridor or
  laryngeal injury if it does not improve in 24–48 h.
- **Recurrence risk.** No pathogen identification means re-emergence of
  fever or new infiltrate would require lower threshold for repeat
  cultures and possible bronchoscopy.

## Pending
- Final urine culture (preliminary no growth at 24 h).
- Anaerobic blood culture bottles still incubating to 5 days.
- PT/OT consult planned tomorrow for early mobility.
- Discharge medication reconciliation: pending decision on metformin and
  furosemide resumption; outpatient nephrology and pulmonology follow-up
  to be arranged.

## Next watch (12–24 h)
- **Respiratory:** wean HFNC to nasal cannula overnight if tolerated;
  watch for re-intubation criteria (RR >30, accessory muscle use,
  desaturation despite escalation).
- **Hemodynamics:** stable but watch BP after amlodipine resumed and
  losartan to be added tomorrow.
- **Infection:** monitor for new fever, leukocytosis, or hemodynamic
  changes that would prompt repeat cultures.
- **Renal:** continue to hold metformin and furosemide until discharge
  planning; watch for fluid retention now that resuscitation phase is
  over.
- **Mobility:** out of bed for the first time tomorrow with PT — assess
  for orthostatic intolerance, deconditioning, ICU-acquired weakness.

## Held home medications (current state)
- metformin — held for AKI/sepsis; reassess at discharge
- losartan — to resume 04-22 if BP stable
- furosemide — held; reassess at discharge based on volume status
- amlodipine — RESUMED 04-21 at 15:00 [evt-002-0140]
- continued: omeprazole (resume PO), atorvastatin, ASA 81

## Code status
Full code; husband HCP.
